PULSE › Topics › Ai Drug Discovery
Ai Drug Discovery
4 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Argenx agrees to acquire Unnatural Products for up to $1.15 billion, betting on AI-guided macrocycle technology to expand oral peptide drug development.
7 sources
7 articles
v 5
7d ago
◼ Archived
Business
Enveda secures $311 million in venture funding to advance nature-derived AI drugs into clinical trials.
4 sources
4 articles
v 2
54d ago
◼ Archived
Business
AI startup Basecamp Research raises $140 million in an oversubscribed Series C funding round.
5 sources
5 articles
v 3
55d ago
◼ Archived
Business
🔮 fades ✗
An AI-designed drug candidate for lung disease, Rentosertib, has shown potential to reverse biological aging markers in early clinical data.
9 sources
9 articles
v 7
70d ago
\n
\n
\n